2015 Press Releases
Keyword Search
 
2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004
DateTitle 
01/09/15WuXi PharmaTech Provides Update of 2014 Financial Guidance, to Present at J.P. Morgan Healthcare Conference
SHANGHAI , Jan. 9, 2015 /PRNewswire/ -- WuXi PharmaTech (NYSE: WX), a leading open-access R&D capability and technology platform company serving the pharmaceutical, biotechnology, and medical device industries with operations in China and the United States, today announced that it has updated its 2014 financial guidance. The company expects to achieve total revenues for full-year 2014 of approximately $674 million, compared to previous guidance of $670-672 million. The company expects to ach... 
Printer Friendly Version
01/09/15WuXi PharmaTech Acquires NextCODE Health to Create Global Leader in Genomic Medicine
NextCODE and WuXi's Genome Center will offer comprehensive clinical, research, and diagnostic testing products and services worldwide SHANGHAI, Jan. 9, 2015 /PRNewswire/ -- WuXi PharmaTech (Cayman) Inc. (NYSE: WX), a leading open-access R&D capability and technology platform company serving the pharmaceutical, biotechnology, and medical device industries with operations in China and the United States, announces that it has acquired NextCODE Health, a leading genomic analysis... 
Printer Friendly Version
01/05/15WuXi PharmaTech Statement on Recent News Report
SHANGHAI, China, January 5, 2015 /PRNewswire/ -- WuXi PharmaTech stated today that a recent news report regarding purported FDA communication with a company named Novacyl Wuxi Pharmaceutical does not relate to WuXi PharmaTech.... 
Printer Friendly Version
01/05/15WuXi Launches Mobile App to Enable Chemistry-on-the-Go
SHANGHAI, Jan. 5, 2015 /PRNewswire/ -- WuXi PharmaTech (Cayman) Inc. (NYSE: WX), a leading open-access R&D capability and technology platform company serving the pharmaceutical, biotechnology and medical device industries, with operations in China and the United States, announced the launch of WuXi V-Lab, the first mobile app available to the global research community in need of small-molecule compound synthesis.  WuXi V-Lab allows customers to request organic compound synthesis through a mo... 
Printer Friendly Version